Acquired Immunodeficiency Syndrome (AIDS) results from an infection by the Human Immunodeficiency Virus (HIV). This virus specifically attacks a type of white blood cell called a B lymphocyte, also known as a B cell, which plays a crucial role in the adaptive immune system. B cells are responsible for producing antibodies, specialized proteins that recognize and neutralize pathogens like viruses and bacteria. By targeting and destroying these cells, HIV weakens the body’s ability to fight off infections, leading to a range of opportunistic illnesses that characterize AIDS.
Understanding this specific mechanism of HIV infection is fundamental to developing effective treatments and preventive strategies. The knowledge that HIV targets B lymphocytes, along with other immune cells like T lymphocytes, has led to the development of antiretroviral therapies (ART). These therapies aim to suppress viral replication, allowing the immune system to recover and function more effectively. This understanding has revolutionized the prognosis for individuals living with HIV, transforming it from a fatal disease to a manageable chronic condition. Furthermore, this knowledge informs public health initiatives and educational campaigns aimed at preventing HIV transmission.
